Skip to Main Content
All Podcasts

Thyroid Cancer Awareness Month

Transcript

  • 00:00 --> 00:02Funding for Yale Cancer Answers
  • 00:02 --> 00:05is provided by Smilow Cancer
  • 00:05 --> 00:07Hospital and AstraZeneca.
  • 00:07 --> 00:08Welcome to Yale Cancer
  • 00:08 --> 00:09Answers with your host
  • 00:09 --> 00:12Dr. Anees Chagpar. Yale Cancer Answers
  • 00:12 --> 00:14features the latest information on
  • 00:14 --> 00:17cancer care by welcoming oncologists and
  • 00:17 --> 00:19specialists who are on the forefront of
  • 00:19 --> 00:22the battle to fight cancer. This week,
  • 00:22 --> 00:23it's a conversation about thyroid
  • 00:23 --> 00:25cancer with Doctor Grace Lee.
  • 00:25 --> 00:27Doctor Lee is an assistant professor
  • 00:27 --> 00:29of surgery at the Yale School of
  • 00:29 --> 00:31Medicine where Doctor Chagpar is
  • 00:31 --> 00:33a professor of surgical oncology.
  • 00:34 --> 00:36Grace, maybe we can start off by
  • 00:36 --> 00:38you telling us a little bit about
  • 00:38 --> 00:40yourself and about what you do.
  • 00:40 --> 00:43As an endocrine surgeon I
  • 00:43 --> 00:45remove the thyroid, parathyroid in
  • 00:45 --> 00:48adrenal glands for various different
  • 00:48 --> 00:50disorders including cancer.
  • 00:50 --> 00:53My areas of clinical and research
  • 00:53 --> 00:54interest include different
  • 00:54 --> 00:56minimally invasive techniques
  • 00:56 --> 00:59and new imaging techniques for
  • 00:59 --> 01:01treatment of endocrine disorders.
  • 01:01 --> 01:03So let's start off by talking a
  • 01:03 --> 01:05little bit about thyroid cancer.
  • 01:05 --> 01:07After all, it is thyroid
  • 01:07 --> 01:08cancer awareness month.
  • 01:08 --> 01:10So tell us a little bit more about
  • 01:10 --> 01:12the epidemiology of thyroid cancer.
  • 01:12 --> 01:14How many people get diagnosed?
  • 01:14 --> 01:17How many people succumb to their disease?
  • 01:17 --> 01:18How common is this?
  • 01:19 --> 01:23So thyroid cancer is
  • 01:23 --> 01:26number wise, about the eighth most
  • 01:26 --> 01:28common cancer in the US, however,
  • 01:28 --> 01:32it only accounts for about 4% of
  • 01:32 --> 01:34all the new cancers being diagnosed,
  • 01:34 --> 01:37and people who succumb to
  • 01:37 --> 01:38thyroid cancer annually
  • 01:38 --> 01:43we guesstimate at about 2000 so
  • 01:43 --> 01:46it is not as prevalent as
  • 01:46 --> 01:49breast cancer or colon cancer,
  • 01:49 --> 01:52but what's interesting is that new
  • 01:52 --> 01:55diagnoses of thyroid cancers have
  • 01:55 --> 01:57tripled in the past three decades.
  • 01:57 --> 02:00It is one of the most rapidly
  • 02:00 --> 02:02increasing cancers in the US
  • 02:02 --> 02:04but we believe that much of
  • 02:04 --> 02:06the increase owes to the fact
  • 02:06 --> 02:08that we're just catching them
  • 02:08 --> 02:10earlier and more frequently,
  • 02:10 --> 02:12as mentioned before,
  • 02:12 --> 02:13we utilized
  • 02:13 --> 02:17various diagnostic imaging to further
  • 02:17 --> 02:21elucidate many conditions and we
  • 02:21 --> 02:24just catch these incidental thyroid
  • 02:24 --> 02:27nodules while we are just looking
  • 02:27 --> 02:29into our body for different diseases.
  • 02:29 --> 02:32So thyroid nodules are just
  • 02:32 --> 02:34being caught earlier and more
  • 02:34 --> 02:37frequently. Some of these imaging
  • 02:37 --> 02:40studies that patients get include
  • 02:40 --> 02:43CT scans after a car accident.
  • 02:43 --> 02:46Pet CT to survey and other cancers
  • 02:46 --> 02:48such as breast cancer or Melanoma
  • 02:48 --> 02:50or even carotid ultrasound,
  • 02:50 --> 02:52to examine narrowing of
  • 02:52 --> 02:53the carotid arteries.
  • 02:53 --> 02:56Let's dig a little bit more
  • 02:56 --> 02:58into that because I find that statistic
  • 02:58 --> 03:03of a tripling in the rate of thyroid
  • 03:03 --> 03:06cancers to be really quite an awesome,
  • 03:06 --> 03:10not in the sense of awesome 'awesome' but awesome
  • 03:10 --> 03:14in the sense of a huge number deserving of awe.
  • 03:17 --> 03:20What are the risk factors for thyroid cancer?
  • 03:20 --> 03:23I appreciate that you said that
  • 03:23 --> 03:26we think that a lot of this is just because
  • 03:26 --> 03:30of an increasing rate of detection,
  • 03:30 --> 03:33but help us to understand what are the
  • 03:33 --> 03:36etiologic causes of thyroid cancer?
  • 03:36 --> 03:38That's an excellent question,
  • 03:38 --> 03:40if we can actually get down to
  • 03:41 --> 03:43the bottom of why thyroid cancer happens
  • 03:43 --> 03:46perhaps we can even prevent it,
  • 03:46 --> 03:50so there have been many studies that have
  • 03:50 --> 03:53been performed to characterize who are the
  • 03:53 --> 03:56folks that are getting thyroid cancer.
  • 03:56 --> 03:58Why we are catching
  • 03:58 --> 04:00and detecting more of them.
  • 04:00 --> 04:03Some of the risk factors for
  • 04:03 --> 04:06thyroid cancer include being a woman
  • 04:06 --> 04:10and of the Asian race and
  • 04:10 --> 04:13age between 25 to 65 years old.
  • 04:13 --> 04:15Although we do see some
  • 04:15 --> 04:18extreme distribution of ages,
  • 04:18 --> 04:22such as pediatric population versus
  • 04:22 --> 04:25very advanced age population.
  • 04:26 --> 04:27And also having had
  • 04:27 --> 04:30prior radiation treatment to the
  • 04:30 --> 04:34head and neck area as a child or
  • 04:34 --> 04:36having had environmental radiation
  • 04:36 --> 04:39exposure such as a nuclear accident.
  • 04:39 --> 04:41And having a family member with
  • 04:41 --> 04:44history of thyroid disease or
  • 04:44 --> 04:46enlarged thyroid or thyroid cancer.
  • 04:46 --> 04:49And again, the detection catches
  • 04:49 --> 04:51incidental thyroid nodules.
  • 04:51 --> 04:53Not necessarily thyroid cancer.
  • 04:53 --> 04:57So most of these thyroid nodules
  • 04:57 --> 04:59turn out to be benign nodules.
  • 04:59 --> 05:01But because we're catching
  • 05:01 --> 05:03benign nodules,
  • 05:03 --> 05:05we are also seeing the increase
  • 05:05 --> 05:06of thyroid cancer.
  • 05:06 --> 05:08When you talk
  • 05:08 --> 05:09about the risk factors,
  • 05:09 --> 05:11a lot of the things you mentioned
  • 05:11 --> 05:13are things that we cannot change.
  • 05:13 --> 05:16Being a woman, your age,
  • 05:16 --> 05:18your race or ethnicity,
  • 05:18 --> 05:21your family history.
  • 05:21 --> 05:25And the things that are other
  • 05:25 --> 05:28risk factors, exposure to radiation,
  • 05:28 --> 05:31nuclear accidents,
  • 05:31 --> 05:33thankfully, not many of us, I think,
  • 05:33 --> 05:36can claim to have that,
  • 05:36 --> 05:38and certainly sometimes when
  • 05:38 --> 05:40we're exposed to radiation due
  • 05:40 --> 05:42to CT scans or other things,
  • 05:42 --> 05:44those may be beyond
  • 05:44 --> 05:47our control as well.
  • 05:47 --> 05:50Are there any factors that our audience
  • 05:50 --> 05:53might be interested in that increase
  • 05:53 --> 05:56or decrease your risk of thyroid
  • 05:56 --> 05:58cancer that you can control?
  • 05:58 --> 06:00And so I'm thinking here about
  • 06:00 --> 06:02things like an iodine deficiency
  • 06:02 --> 06:06that we know can have a role to
  • 06:06 --> 06:09play in benign thyroid conditions.
  • 06:09 --> 06:12Any role for that in terms of cancers?
  • 06:12 --> 06:16Any other factors that
  • 06:16 --> 06:19people could potentially control?
  • 06:20 --> 06:22That's very interesting question.
  • 06:22 --> 06:26I do occasionally have a patient
  • 06:26 --> 06:30who's interested in modifying their diet
  • 06:30 --> 06:33to either combat the existing thyroid
  • 06:33 --> 06:37cancer or help their family members
  • 06:37 --> 06:40prevent from getting thyroid cancer.
  • 06:40 --> 06:42Iodine deficiency certainly
  • 06:42 --> 06:47can be the cause of a goiter,
  • 06:47 --> 06:48an enlarged thyroid gland.
  • 06:48 --> 06:52But I do not believe there has
  • 06:52 --> 06:54been an established linkage
  • 06:54 --> 06:57between iodine supplementation and
  • 06:57 --> 06:59decreased rate of thyroid cancer.
  • 06:59 --> 07:03So at the current time point,
  • 07:03 --> 07:05I think detection and appropriate treatment
  • 07:05 --> 07:09will be the best course of action
  • 07:09 --> 07:12once one is found to have thyroid cancer.
  • 07:16 --> 07:18Getting back to that original statistic,
  • 07:18 --> 07:20this tripling of thyroid cancers,
  • 07:20 --> 07:23it doesn't seem that there has been
  • 07:23 --> 07:25a tripling of nuclear accidents.
  • 07:25 --> 07:28If anything, I think our nuclear
  • 07:28 --> 07:30exposures have generally declined,
  • 07:30 --> 07:34as safety protocols have improved,
  • 07:34 --> 07:37one wouldn't think that there
  • 07:37 --> 07:40would have been a difference in terms of
  • 07:40 --> 07:44age or gender or race over the last
  • 07:44 --> 07:46few decades where we've seen this
  • 07:46 --> 07:49tripling and so that brings us to
  • 07:49 --> 07:51this whole area of of detection,
  • 07:51 --> 07:54which you surmise is really the
  • 07:54 --> 07:58thing at the driving seat of
  • 07:58 --> 08:00this tripling of thyroid cancer.
  • 08:00 --> 08:02Has anybody looked at that?
  • 08:02 --> 08:05Has the rate at which we are imaging
  • 08:05 --> 08:09people increased at that same proportion?
  • 08:09 --> 08:12So in other words we all know that
  • 08:12 --> 08:15there's been this burgeoning of technology.
  • 08:15 --> 08:18And we seem to do more imaging
  • 08:18 --> 08:20nowadays than we used to.
  • 08:20 --> 08:22At least that's how it feels anecdotally.
  • 08:22 --> 08:24But has anybody looked at that to see
  • 08:24 --> 08:26whether these two trends are parallel?
  • 08:27 --> 08:29Yeah, I believe so.
  • 08:29 --> 08:32So in much of thyroid cancer literature,
  • 08:32 --> 08:37we always attribute the partial rapid
  • 08:37 --> 08:42increase in thyroid cancer being
  • 08:42 --> 08:45prevalent to essentially the detection,
  • 08:45 --> 08:48in leading to earlier diagnosis,
  • 08:48 --> 08:52not necessarily more aggressive treatment,
  • 08:52 --> 08:56we have been scaling back down on the
  • 08:56 --> 09:00resection of these thyroid cancers.
  • 09:00 --> 09:03So not all thyroid cancers lead to surgery,
  • 09:03 --> 09:07but it is certainly true that there
  • 09:07 --> 09:10is clear correlation between the
  • 09:10 --> 09:13utilization of imaging studies
  • 09:13 --> 09:16in multiple different aspects.
  • 09:16 --> 09:19And also perhaps patient awareness
  • 09:19 --> 09:23in clinician exam skills being
  • 09:23 --> 09:27improved lead to detection of the
  • 09:27 --> 09:31thyroid nodules and go down the
  • 09:31 --> 09:32pathway of thyroid cancer detection.
  • 09:33 --> 09:34Let's talk a little bit
  • 09:34 --> 09:35about that because as you say,
  • 09:35 --> 09:37not all thyroid nodules that
  • 09:37 --> 09:38may be picked up incidentally,
  • 09:38 --> 09:41either on imaging or on physical
  • 09:41 --> 09:43exam are actually a cancer.
  • 09:43 --> 09:46So let's suppose somebody does have
  • 09:46 --> 09:49a scan done for whatever reason
  • 09:49 --> 09:51and the thyroid nodule is found.
  • 09:51 --> 09:54How do we get from incidental thyroid
  • 09:54 --> 09:58nodule to making a diagnosis of cancer?
  • 09:58 --> 09:59How does that work?
  • 09:59 --> 10:02Yeah, so as we mentioned,
  • 10:02 --> 10:05it is not uncommon that we just
  • 10:05 --> 10:07stumble upon a thyroid nodule being
  • 10:07 --> 10:11mentioned on a CT scan that a patient
  • 10:11 --> 10:15may have gotten for neck pain or
  • 10:15 --> 10:20just to rule out lung nodules etc.
  • 10:20 --> 10:23So after initial detection of the
  • 10:23 --> 10:27thyroid nodule on a different modality,
  • 10:27 --> 10:30we do a comprehensive neck
  • 10:30 --> 10:34ultrasound as the gold standard exam.
  • 10:36 --> 10:39If the patient does not have recent
  • 10:39 --> 10:42thyroid function that was drawn
  • 10:42 --> 10:45with a routine yearly checkup.
  • 10:45 --> 10:49So after the ultrasound is obtained,
  • 10:49 --> 10:52we can then
  • 10:52 --> 10:54detect whether the thyroid nodule
  • 10:54 --> 10:58is of the appropriate size and if
  • 10:58 --> 11:01that nodule has specific ultrasound
  • 11:01 --> 11:04characteristics that make us worried
  • 11:04 --> 11:08about that thyroid nodule being cancerous.
  • 11:08 --> 11:10And if we
  • 11:10 --> 11:13give that thyroid nodule appropriate
  • 11:13 --> 11:18numbers and if we surmise that the
  • 11:18 --> 11:21nodule is meeting the biopsy criteria,
  • 11:21 --> 11:24then what we usually do is
  • 11:24 --> 11:27a fine needle aspiration biopsy
  • 11:27 --> 11:30under the guidance of ultrasound
  • 11:30 --> 11:32to have our pathologists then take
  • 11:32 --> 11:35a look at some of the cell samples
  • 11:35 --> 11:37obtained from their thyroid nodule.
  • 11:38 --> 11:40So let's flush that out a little bit.
  • 11:40 --> 11:41You mentioned that
  • 11:41 --> 11:43there are some size criteria,
  • 11:43 --> 11:45some morphologic criteria that you
  • 11:45 --> 11:48look at in terms of a thyroid nodule
  • 11:48 --> 11:51to kind of gauge your suspicion as to
  • 11:51 --> 11:54whether this could be malignant or not,
  • 11:54 --> 11:56tell us a little bit more
  • 11:56 --> 11:57about what those criteria are.
  • 11:57 --> 11:59What are the things that make you worried
  • 11:59 --> 12:02that a thyroid nodule could be cancer?
  • 12:02 --> 12:06Yeah, so generally speaking we
  • 12:06 --> 12:10worry about bigger thyroid nodules.
  • 12:10 --> 12:14That's generally speaking.
  • 12:14 --> 12:16And how big is big grade?
  • 12:17 --> 12:20We consider anything less than
  • 12:20 --> 12:241 centimeter as kind of
  • 12:24 --> 12:28microterritory and 1 centimeter or greater
  • 12:28 --> 12:31at least meets the size criteria.
  • 12:31 --> 12:35If the thyroid nodule looks worrisome
  • 12:35 --> 12:39enough on the ultrasound and some of the
  • 12:39 --> 12:42worrisome features are the thyroid nodule
  • 12:42 --> 12:48being solid rather than mostly fluid,
  • 12:48 --> 12:50or mixed solid and fluid,
  • 12:50 --> 12:54what we call cystic and it has what
  • 12:54 --> 12:56we call hypoechoic characteristic
  • 12:56 --> 12:59onto ultrasound microcalcifications
  • 12:59 --> 13:04irregular borders taller than wide, etc.
  • 13:04 --> 13:08So we radiologists are very familiar
  • 13:08 --> 13:11with assigning certain
  • 13:11 --> 13:13points to these thyroid nodules
  • 13:13 --> 13:18to see if this is thyroid nodule
  • 13:18 --> 13:21should then proceed to the
  • 13:21 --> 13:23biopsy stage or
  • 13:23 --> 13:25this thyroid nodule looks
  • 13:25 --> 13:28to be pretty innocuous.
  • 13:28 --> 13:29Although it is 2 centimeters
  • 13:29 --> 13:31or three centimeters,
  • 13:31 --> 13:33and perhaps we can watch it.
  • 13:34 --> 13:37And so we're going to pick up on
  • 13:37 --> 13:38this conversation about what happens
  • 13:38 --> 13:40once that diagnosis of thyroid
  • 13:40 --> 13:43cancer is made right after we take
  • 13:43 --> 13:45a short break for a medical minute.
  • 13:45 --> 13:47Please stay tuned to learn more about
  • 13:47 --> 13:49the care of patients with thyroid
  • 13:49 --> 13:51cancer with my guest doctor Grace Lee.
  • 13:52 --> 13:54Support for Yale Cancer Answers
  • 13:54 --> 13:56comes from Smilow Cancer Hospital,
  • 13:56 --> 13:58where an individualized approach to
  • 13:58 --> 13:59prostate cancer screening is used
  • 14:00 --> 14:02to determine which men are eligible
  • 14:02 --> 14:03and would benefit from screening.
  • 14:03 --> 14:07To learn more, visit Yale Cancer
  • 14:07 --> 14:09Center dot org slash screening.
  • 14:09 --> 14:11Genetic testing can be useful for
  • 14:11 --> 14:13people with certain types of cancer
  • 14:13 --> 14:15that seem to run in their families.
  • 14:15 --> 14:18Genetic counseling is a process that
  • 14:18 --> 14:20includes collecting a detailed personal
  • 14:20 --> 14:22and family history or risk assessment and
  • 14:22 --> 14:25a discussion of genetic testing options.
  • 14:25 --> 14:27Only about 5 to 10% of all
  • 14:27 --> 14:28cancers are inherited,
  • 14:28 --> 14:30and genetic testing is not
  • 14:30 --> 14:32recommended for everyone.
  • 14:32 --> 14:34Individuals who have a personal and
  • 14:34 --> 14:36or family history that includes
  • 14:36 --> 14:38cancer at unusually early ages,
  • 14:38 --> 14:39multiple relatives
  • 14:39 --> 14:41on the same side of the family
  • 14:41 --> 14:43with the same cancer,
  • 14:43 --> 14:45more than one diagnosis of
  • 14:45 --> 14:46cancer in the same individual,
  • 14:46 --> 14:49rare cancers or family history of a
  • 14:49 --> 14:51known altered cancer predisposing gene
  • 14:51 --> 14:55could be candidates for genetic testing.
  • 14:55 --> 14:57Resources for genetic counseling and
  • 14:57 --> 14:59testing are available at federally
  • 14:59 --> 15:00designated comprehensive cancer
  • 15:00 --> 15:03centers such as Yale Cancer Center
  • 15:03 --> 15:04and Smilow Cancer Hospital.
  • 15:04 --> 15:08More information is available at
  • 15:08 --> 15:09yalecancercenter.org. You're listening
  • 15:09 --> 15:11to Connecticut Public Radio.
  • 15:11 --> 15:14Welcome back to Yale Cancer Answers.
  • 15:14 --> 15:16This is doctor Anees Chagpar and I'm
  • 15:16 --> 15:19joined tonight by my guest Doctor Grace Lee.
  • 15:19 --> 15:21We're talking about the care of
  • 15:21 --> 15:23patients with thyroid cancer in
  • 15:23 --> 15:26honor of Thyroid Cancer Awareness
  • 15:26 --> 15:27Month and right before the break,
  • 15:27 --> 15:30Grace was telling us this amazing
  • 15:30 --> 15:32statistic that thyroid cancers have
  • 15:32 --> 15:35actually tripled in recent history
  • 15:35 --> 15:38in large part due to an increase
  • 15:38 --> 15:39in standard imaging.
  • 15:39 --> 15:41So we're stumbling upon these
  • 15:41 --> 15:43incidental thyroid nodules,
  • 15:43 --> 15:46which, if they're large enough,
  • 15:46 --> 15:49and if they have certain
  • 15:49 --> 15:51morphologic features on ultrasound,
  • 15:51 --> 15:55are warranting a biopsy and that biopsy
  • 15:55 --> 15:58can sometimes reveal thyroid cancers.
  • 15:58 --> 15:59So Grace,
  • 15:59 --> 16:03before the break you were mentioning that
  • 16:03 --> 16:06thyroid cancer is not a uniform disease.
  • 16:06 --> 16:08It's not homogeneous.
  • 16:08 --> 16:12Not all thyroid cancers are treated the same.
  • 16:12 --> 16:14So tell us a little bit more about that.
  • 16:14 --> 16:16First of all,
  • 16:16 --> 16:19are there different kinds of thyroid cancer?
  • 16:19 --> 16:21And second of all,
  • 16:21 --> 16:24how does that impact what you do next?
  • 16:24 --> 16:25There are
  • 16:25 --> 16:28about four different major
  • 16:28 --> 16:31types of thyroid cancers.
  • 16:31 --> 16:35The good news is that the most
  • 16:35 --> 16:38common thyroid cancer known as
  • 16:38 --> 16:40papillary thyroid cancer actually
  • 16:40 --> 16:43carries the best prognosis.
  • 16:43 --> 16:48So most people, about 90% of the
  • 16:48 --> 16:50patients that I treat come in
  • 16:50 --> 16:53with papillary thyroid cancer,
  • 16:53 --> 16:58and the rest, 10% comprise of
  • 16:58 --> 17:01other follicular medullary or
  • 17:01 --> 17:03anaplastic thyroid cancers.
  • 17:03 --> 17:06And other good news is that seven
  • 17:06 --> 17:09out of those ten patients recently
  • 17:09 --> 17:12diagnosed with thyroid cancer come in
  • 17:12 --> 17:15with the cancer that is well behaving,
  • 17:15 --> 17:19meaning their cancer has not actually
  • 17:19 --> 17:22spread outside of the thyroid.
  • 17:22 --> 17:25So most of the people who get
  • 17:25 --> 17:27the diagnosis of thyroid cancer,
  • 17:27 --> 17:30although it is quite terrifying,
  • 17:30 --> 17:33should be reassured that as
  • 17:33 --> 17:35long as we treat them
  • 17:35 --> 17:39the right way they're going to
  • 17:39 --> 17:42be enjoying excellent prognosis.
  • 17:42 --> 17:44Tell us a little bit
  • 17:44 --> 17:47more about that, I mean
  • 17:47 --> 17:4990% of patients have papillary
  • 17:49 --> 17:52cancers which have a good prognosis.
  • 17:52 --> 17:57Of those, 70% are well behaved,
  • 17:57 --> 17:59but these patients still
  • 17:59 --> 18:00require treatment, right?
  • 18:00 --> 18:03Or is it that thyroid cancer has
  • 18:03 --> 18:05now gone the way of other cancers
  • 18:06 --> 18:07in terms of watchful waiting?
  • 18:08 --> 18:13That's a hotly debated
  • 18:13 --> 18:17very individualized choice, but the
  • 18:17 --> 18:22mainstay treatment for thyroid cancer,
  • 18:22 --> 18:25first and foremost is surgical,
  • 18:25 --> 18:28or if the cancer has gone
  • 18:28 --> 18:29outside of the thyroid,
  • 18:29 --> 18:34then we would treat by removing the entire
  • 18:34 --> 18:39thyroid as well as the involved lymph nodes.
  • 18:39 --> 18:42Watchful waiting in the thyroid world,
  • 18:42 --> 18:45we call that active surveillance.
  • 18:45 --> 18:51We can sometimes employ that approach,
  • 18:51 --> 18:53which is another right answer to
  • 18:53 --> 18:55this thyroid cancer management.
  • 18:55 --> 18:58We can go active surveillance route
  • 18:58 --> 19:01if the papillary thyroid cancer,
  • 19:01 --> 19:03the well behaving thyroid cancer
  • 19:03 --> 19:06happens to be less than one centimeter.
  • 19:06 --> 19:09So if there is no risk of this
  • 19:09 --> 19:12cancer invading into the nerve or
  • 19:12 --> 19:16the cancer going outside of the
  • 19:16 --> 19:19thyroid is well cushioned by normal
  • 19:19 --> 19:22thyroid and the patient is very
  • 19:22 --> 19:25motivated and reliable to comply with
  • 19:25 --> 19:28this active surveillance program.
  • 19:28 --> 19:32We can certainly go that route,
  • 19:32 --> 19:35but any thyroid cancer that is between
  • 19:35 --> 19:38one centimeter to 4 centimeter
  • 19:39 --> 19:42can go either half of the thyroid
  • 19:42 --> 19:45that's containing that cancer or the
  • 19:45 --> 19:48entire thyroid to be removed.
  • 19:48 --> 19:51So there are multiple right answers.
  • 20:02 --> 20:03Let me just pick up
  • 20:03 --> 20:05on a couple of things there.
  • 20:05 --> 20:07So the first thing is in
  • 20:07 --> 20:09terms of active surveillance.
  • 20:09 --> 20:11This is for people who have papillary
  • 20:11 --> 20:13cancers that are well differentiated
  • 20:13 --> 20:16that are less than one centimeter.
  • 20:20 --> 20:22What does active surveillance
  • 20:22 --> 20:23actually entail?
  • 20:23 --> 20:26I mean, is this an ultrasound
  • 20:26 --> 20:29every six months to make sure that
  • 20:29 --> 20:31this thyroid nodule isn't growing?
  • 20:31 --> 20:33Is it blood work?
  • 20:33 --> 20:35Is it CT scans?
  • 20:35 --> 20:37What exactly does that entail?
  • 20:37 --> 20:40Great question. Yes,
  • 20:40 --> 20:48it would mean actively monitoring the size
  • 20:48 --> 20:52or the growth changes of that biopsy
  • 20:52 --> 20:55known micro papillary thyroid cancer
  • 20:55 --> 20:59and is some clinician dependent,
  • 20:59 --> 21:02but usually about every six months
  • 21:02 --> 21:06to a year ultrasound exam and the
  • 21:06 --> 21:10thyroid cancer is not something that
  • 21:10 --> 21:13we follow on laboratory values.
  • 21:13 --> 21:15So it's heavily
  • 21:15 --> 21:19image independent and sometimes even a
  • 21:19 --> 21:24neck CT is utilized to pick up on lymph
  • 21:24 --> 21:29node spread a little bit more closely.
  • 21:29 --> 21:33It is what's called a wolf in sheep
  • 21:33 --> 21:36clothing by one of my mentors because
  • 21:36 --> 21:40even micro papillary cancer can spread to
  • 21:40 --> 21:43nearby lymph nodes in the thyroid cancer world,
  • 21:43 --> 21:46even the lymphatic spread does not
  • 21:46 --> 21:49necessarily mean worse prognosis.
  • 21:49 --> 21:51However, it is more advanced
  • 21:51 --> 21:54or at least local,
  • 21:54 --> 21:56regionally advanced disease.
  • 21:56 --> 21:59So we treat those folks
  • 21:59 --> 22:02almost as equally as someone who has
  • 22:02 --> 22:06bigger cancer and the folks that I'm
  • 22:06 --> 22:09talking about are patients under active
  • 22:09 --> 22:13surveillance and by watching them carefully,
  • 22:13 --> 22:15it may earn them,
  • 22:15 --> 22:18or it may buy them an extra five years
  • 22:18 --> 22:22extra 10 years with their own thyroid.
  • 22:22 --> 22:26And surgical
  • 22:26 --> 22:29treatment always is an option.
  • 22:29 --> 22:31But generally speaking,
  • 22:31 --> 22:33if the size of that micro cancer
  • 22:34 --> 22:36changes by about 3 millimeters,
  • 22:36 --> 22:38we say, well, OK.
  • 22:38 --> 22:41I think it's time to intervene,
  • 22:41 --> 22:43and most of the studies on
  • 22:43 --> 22:45active surveillance comes out of
  • 22:45 --> 22:48Japan and their long term result
  • 22:48 --> 22:50is actually quite excellent.
  • 22:51 --> 22:52So you really are watching
  • 22:52 --> 22:53these people very closely.
  • 22:53 --> 22:56I mean, even 3 millimeters doesn't sound
  • 22:56 --> 22:59like a whole lot to the people
  • 22:59 --> 23:00who are listening to our show today,
  • 23:00 --> 23:03I'm sure, but really
  • 23:03 --> 23:07that is going to trigger you moving to
  • 23:07 --> 23:10a more aggressive surgical approach
  • 23:10 --> 23:12as opposed to active surveillance.
  • 23:12 --> 23:14My next question has to do
  • 23:14 --> 23:15with that surgical approach.
  • 23:15 --> 23:18You mentioned that for people who have
  • 23:18 --> 23:21larger tumors, so larger than one centimeter,
  • 23:21 --> 23:24you could do a partial thyroidectomy,
  • 23:24 --> 23:27take out just that part of the
  • 23:27 --> 23:28thyroid that had the cancer.
  • 23:28 --> 23:31Or you could take out the whole
  • 23:31 --> 23:33thyroid and you said this
  • 23:33 --> 23:36is really a decision that's made by
  • 23:36 --> 23:38the team and is personalized
  • 23:38 --> 23:43what factors go into deciding what kind
  • 23:43 --> 23:46of an operation a patient should have?
  • 23:47 --> 23:49One would think that it's a big
  • 23:49 --> 23:51difference between having only part of your
  • 23:51 --> 23:53thyroid removed and having your
  • 23:53 --> 23:54whole thyroid removed?
  • 23:54 --> 23:57Yes, this is a discussion
  • 23:57 --> 24:00that I get to have multiple times a week,
  • 24:00 --> 24:04so I usually talk about the benefits first
  • 24:04 --> 24:08of only removing half of the thyroid and
  • 24:08 --> 24:12this is a change that the American
  • 24:12 --> 24:14Thyroid Association instituted
  • 24:14 --> 24:18in 2015 because there is such a
  • 24:18 --> 24:20increase in the prevalence of
  • 24:20 --> 24:24thyroid cancers, so perhaps a less
  • 24:24 --> 24:26aggressive approach is warranted,
  • 24:26 --> 24:29as I think what the experts were thinking,
  • 24:29 --> 24:32so the benefit of only removing half
  • 24:32 --> 24:34of the thyroid that contains cancer
  • 24:34 --> 24:38is that there is a pretty good chance
  • 24:38 --> 24:40that the remaining thyroid may be
  • 24:40 --> 24:44able to pick up the missing half and
  • 24:44 --> 24:48still give you enough thyroid hormone.
  • 24:50 --> 24:53So if you lose the entire thyroid,
  • 24:53 --> 24:56you will have to take a thyroid
  • 24:56 --> 24:59hormone supplementation pill everyday.
  • 24:59 --> 25:03But if you have at least half of a thyroid,
  • 25:03 --> 25:04that is normal
  • 25:04 --> 25:05remaining in you,
  • 25:05 --> 25:07there is a pretty good chance that you
  • 25:07 --> 25:11may be able to avoid the medication aspect,
  • 25:11 --> 25:13so that's one plus.
  • 25:13 --> 25:18And although the thyroid surgery is
  • 25:18 --> 25:22very safe when done in expert hands and
  • 25:22 --> 25:26known to have very low complication rate it
  • 25:26 --> 25:29will double the amount of thyroid
  • 25:29 --> 25:32resection and obviously put you at
  • 25:32 --> 25:36double the risk of complications,
  • 25:36 --> 25:39so those are some of the things
  • 25:39 --> 25:40that we discuss.
  • 25:40 --> 25:45Obviously if one thyroid nodule
  • 25:45 --> 25:47was biopsied
  • 25:47 --> 25:51happens to have some genetic mutations,
  • 25:51 --> 25:55such as a brief V600 E mutation.
  • 25:55 --> 25:58Or if the patient has
  • 25:58 --> 25:59Hashimoto's thyroiditis,
  • 25:59 --> 26:02has a family history of thyroid cancer,
  • 26:02 --> 26:05or has another sizable nodule
  • 26:05 --> 26:08on the other side,
  • 26:08 --> 26:10then maybe it's better for us
  • 26:10 --> 26:13to do an up front
  • 26:13 --> 26:16total removal of the thyroid so
  • 26:16 --> 26:19we can catch perhaps multiple
  • 26:19 --> 26:22spots of thyroid cancer,
  • 26:22 --> 26:25which is a pretty well known
  • 26:25 --> 26:28phenomenon in thyroid cancer patients.
  • 26:28 --> 26:31So those are some of the considerations
  • 26:31 --> 26:33when we discuss should we take
  • 26:33 --> 26:36out half or the entire thyroid?
  • 26:36 --> 26:38And of course,
  • 26:38 --> 26:41if the patient happens to have
  • 26:41 --> 26:43the lymph node spread
  • 26:43 --> 26:45already outside the thyroid
  • 26:45 --> 26:48and then the discussion is OK,
  • 26:48 --> 26:51we should just go ahead and remove the
  • 26:51 --> 26:53entire thyroid and the compartments
  • 26:53 --> 26:56where the diseased lymph nodes are and
  • 26:56 --> 26:59so it sounds like if the thyroid
  • 26:59 --> 27:01is otherwise pretty healthy,
  • 27:01 --> 27:05no Hashimoto's, no other nodules
  • 27:05 --> 27:09and the thyroid cancer itself has
  • 27:09 --> 27:13not spread to lymph nodes.
  • 27:13 --> 27:15But still is more than one centimeter.
  • 27:15 --> 27:17It sounds like your general
  • 27:17 --> 27:19recommendation is a partial thyroidectomy.
  • 27:19 --> 27:19Is that right?
  • 27:20 --> 27:21That's right.
  • 27:24 --> 27:26So far we've been
  • 27:26 --> 27:28talking about papillary cancers,
  • 27:28 --> 27:29if it was one of the other kinds,
  • 27:29 --> 27:31the follicular, the medullary,
  • 27:31 --> 27:32the anaplastic,
  • 27:32 --> 27:34that 10% that we were talking
  • 27:34 --> 27:36about at the top of the show,
  • 27:37 --> 27:38does that change your mind?
  • 27:38 --> 27:42Yes, so in the case of medullary thyroid
  • 27:42 --> 27:44cancer, thank goodness is pretty rare,
  • 27:44 --> 27:50but there is a genetic disposition and the
  • 27:50 --> 27:53cancer itself portends to worse prognosis.
  • 27:53 --> 27:57We would be doing at minimum total thyroid
  • 27:57 --> 28:00surgery and what's called central neck
  • 28:00 --> 28:03lymph node dissection from the get go.
  • 28:03 --> 28:06So the extent that we talk
  • 28:06 --> 28:09about for different types of
  • 28:09 --> 28:11thyroid cancer very drastically.
  • 28:11 --> 28:14And of course in the case of
  • 28:14 --> 28:15anaplastic thyroid cancer,
  • 28:15 --> 28:19if the patient is a surgical candidate,
  • 28:19 --> 28:22then we can certainly attempt to reset
  • 28:22 --> 28:26or debulk the bulk of the disease.
  • 28:26 --> 28:29But the unfortunate part is that anaplastic
  • 28:29 --> 28:31thyroid cancer is often incurable.
  • 28:32 --> 28:34Doctor Grace Lee is an assistant professor
  • 28:34 --> 28:37of surgery at the Yale School of Medicine.
  • 28:37 --> 28:39If you have questions,
  • 28:39 --> 28:41the addresses cancer answers at
  • 28:41 --> 28:43yale.edu and past editions of the
  • 28:43 --> 28:46program are available in audio and
  • 28:46 --> 28:47written form at yalecancercenter.org.
  • 28:47 --> 28:50We hope you'll join us next week to
  • 28:50 --> 28:52learn more about the fight against
  • 28:52 --> 28:53cancer here on Connecticut Public
  • 28:53 --> 28:55radio funding for Yale Cancer
  • 28:55 --> 28:57Answers is provided by Smilow
  • 28:57 --> 29:00Cancer Hospital and AstraZeneca.